Janux Therapeutics, Inc. (JANX)
14.04
-0.21
(-1.47%)
USD |
NASDAQ |
Dec 29, 16:00
13.90
-0.14
(-1.00%)
After-Hours: 20:00
Janux Therapeutics Shareholders Equity (Quarterly): 976.56M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | 23.79B |
| Stoke Therapeutics, Inc. | 308.10M |
| Ionis Pharmaceuticals, Inc. | 617.97M |
| MannKind Corp. | -44.55M |
| Madrigal Pharmaceuticals, Inc. | 625.73M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.025B |
| Total Liabilities (Quarterly) | 48.21M |
| Debt to Equity Ratio | 0.0232 |
| Current Ratio | 35.86 |
| Net Debt Paydown Yield | 0.02% |